 | Up a level |
Hermann, Laura; Schöning, Verena; Dräger, Sarah; Rentsch, Katharina; Moser, Stephan; Gürtler, Nicolas; Sendi, Parham; Osthoff, Michael; Hammann, Felix (2024). Population pharmacokinetics of flucloxacillin as intermittent bolus infusion in patients with Staphylococcus aureus bloodstream infection. The journal of antimicrobial chemotherapy, 79(8), pp. 2031-2039. Oxford University Press 10.1093/jac/dkae207
Chaccour, Carlos; Casellas, Aina; Hammann, Felix; Ruiz-Castillo, Paula; Nicolas, Patricia; Montaña, Julia; Mael, Mary; Selvaraj, Prashant; Duthaler, Urs; Mrema, Sigilbert; Kakolwa, Mwaka; Lyimo, Issa; Okumu, Fredros; Marathe, Achla; Schürch, Roger; Elobolobo, Eldo; Sacoor, Charfudin; Saute, Francisco; Xia, Kang; Jones, Caroline; ... (2023). BOHEMIA: Broad One Health Endectocide-based Malaria Intervention in Africa-a phase III cluster-randomized, open-label, clinical trial to study the safety and efficacy of ivermectin mass drug administration to reduce malaria transmission in two African settings. Trials, 24(1), p. 128. BioMed Central 10.1186/s13063-023-07098-2
Schöning, Verena; Liakoni, Evangelia; Baumgartner, Christine; Exadaktylos, Aristomenis K; Hautz, Wolf E; Atkinson, Andrew; Hammann, Felix (2022). Revalidating the prognostic COVID-19 severity assessment (COSA) score for variants of concern. Journal of translational medicine, 20(1), p. 427. BioMed Central 10.1186/s12967-022-03634-x
Schöning, Verena; Hammann, Felix (2022). Drug-Disease Severity and Target-Disease Severity Interaction Networks in COVID-19 Patients. Pharmaceutics, 14(9) MDPI 10.3390/pharmaceutics14091828
